Primary Retroperitoneal Myxoid Liposarcomas

Nokitaka Setsu1, Mototaka Miyake, Susumu Wakai

  • 1Departments of *Pathology and Clinical Laboratories †Musculoskeletal Oncology §Diagnostic Radiology ‡Rare Cancer Center, National Cancer Center Hospital, Tokyo, Japan.

Insights

Primary retroperitoneal myxoid liposarcomas (MLSs) are rare but can occur. This study confirms their existence and provides diagnostic criteria using clinicopathologic and molecular analysis.

Area of Science:

  • Oncology
  • Pathology
  • Genetics

Background:

  • Myxoid liposarcomas (MLSs) are typically found in extremities and defined by DDIT3 gene fusions.
  • The primary origin of MLSs in the retroperitoneum is debated, with some cases potentially misidentified metastases or other liposarcoma subtypes.
  • Distinguishing primary retroperitoneal MLSs from other liposarcomas with myxoid features, such as those with MDM2 amplifications, is clinically important.

Purpose of the Study:

  • To investigate and confirm the occurrence of primary myxoid liposarcomas originating in the retroperitoneum.
  • To establish diagnostic criteria for retroperitoneal MLSs through clinicopathologic and molecular evaluation.
  • To differentiate primary retroperitoneal MLSs from other liposarcoma subtypes.

Main Methods:

  • Clinicopathologic reevaluation of 5 cases of retroperitoneal liposarcomas with myxoid features.
  • Histologic examination for classic myxoid liposarcoma findings.
  • Fluorescence in situ hybridization (FISH) to detect DDIT3 gene rearrangements and MDM2 amplifications.

Main Results:

  • Five cases of primary retroperitoneal MLSs were identified, representing 2.3% of primary retroperitoneal liposarcomas in the database.
  • Patients (3 male, 2 female) had a median age of 32 years; tumors were localized to the retroperitoneum at presentation.
  • All 5 cases showed focal classic histologic features, harbored DDIT3 gene rearrangements, and lacked MDM2 amplifications.

Conclusions:

  • Primary myxoid liposarcomas can rarely originate in the retroperitoneum.
  • Accurate diagnosis requires a combination of clinicopathologic assessment and molecular analysis (DDIT3 rearrangements).
  • This study clarifies the existence of primary retroperitoneal MLSs, distinguishing them from metastatic disease or other liposarcoma subtypes.